Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Refines Requirements For Computer-Aided Detection

This article was originally published in The Gray Sheet

Executive Summary

FDA published two draft guidance documents Oct. 21 to help firms through 510(k) or PMA submissions for computer-aided detection tools; on the following day, the agency announced an upcoming panel meeting on the topic
Advertisement

Related Content

FDA Eases Clinical Requirements For Some Computer-Assisted Detection Devices
No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
No Clinical Data Needed For Some Computer-Aided Detection Devices - Panel
FDA Whistleblower Letter Released At Sebelius Confirmation Hearing
CAD Mammography Leads To Unnecessary Patient Recalls, Biopsies – ECRI
CAD Mammography Leads To Unnecessary Patient Recalls, Biopsies – ECRI

Topics

Advertisement
UsernamePublicRestriction

Register

MT028081

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel